Gluconeogenesis
Gluconeogenesis is a crucial metabolic pathway involving the biosynthesis of glucose from nonhexose or non-carbohydrate precursors, such as lactate, pyruvate, alanine, and glycerol. This process plays a significant role in maintaining glucose homeostasis, particularly during periods of fasting or intense exercise when glucose reserves are depleted.
Pathway[edit]
The gluconeogenesis pathway is largely a reversal of glycolysis, utilizing several of the same enzymes. However, it includes three key steps that bypass the irreversibly regulated steps of glycolysis. These steps involve the enzymes pyruvate carboxylase, phosphoenolpyruvate carboxykinase (PEPCK), fructose 1,6-bisphosphatase, and glucose 6-phosphatase.
Regulation[edit]
Gluconeogenesis is tightly regulated at both the gene expression and enzymatic activity levels. It's primarily regulated by hormones such as insulin and glucagon, which respectively inhibit and stimulate the process in response to blood glucose levels. Certain enzymes within the pathway are also allosterically regulated by various metabolites.
Clinical Significance[edit]
Disturbances in gluconeogenesis can lead to metabolic disorders, including hypoglycemia and hyperglycemia. For instance, excessive gluconeogenesis contributes to the elevated blood glucose levels observed in type 2 diabetes.
References[edit]
See Also[edit]
- Glycolysis
- Pyruvate Carboxylase
- Phosphoenolpyruvate Carboxykinase
- Fructose 1,6-Bisphosphatase
- Glucose 6-Phosphatase
- Insulin
- Glucagon
-
Amino acid catabolism
-
Gluconeogenesis pathway
-
Metabolism of common monosaccharides and related reactions
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
